Business Description
Syntara Ltd
NAICS : 325412
SIC : 2834
ISIN : AU0000312480
Description
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.57 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -23.58 | |||||
| Beneish M-Score | -5.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.6 | |||||
| 3-Year EBITDA Growth Rate | 32.7 | |||||
| 3-Year EPS without NRI Growth Rate | 21.4 | |||||
| 3-Year FCF Growth Rate | 32 | |||||
| 3-Year Book Growth Rate | 48.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.8 | |||||
| 9-Day RSI | 44.09 | |||||
| 14-Day RSI | 42.53 | |||||
| 6-1 Month Momentum % | -34.38 | |||||
| 12-1 Month Momentum % | -61.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.75 | |||||
| Quick Ratio | 1.75 | |||||
| Cash Ratio | 0.77 | |||||
| Days Inventory | 435.01 | |||||
| Days Sales Outstanding | 266.89 | |||||
| Days Payable | 632.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.1 | |||||
| Shareholder Yield % | -3.52 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.55 | |||||
| Operating Margin % | -458.85 | |||||
| Net Margin % | -277.28 | |||||
| FCF Margin % | -248.71 | |||||
| ROE % | -118.54 | |||||
| ROA % | -54.45 | |||||
| ROIC % | -236.13 | |||||
| ROC (Joel Greenblatt) % | -489.15 | |||||
| ROCE % | -91.73 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.83 | |||||
| PB Ratio | 2.13 | |||||
| Price-to-Tangible-Book | 1.7 | |||||
| EV-to-EBIT | -1.09 | |||||
| EV-to-EBITDA | -1.14 | |||||
| EV-to-Revenue | 3.36 | |||||
| EV-to-Forward-Revenue | 2.15 | |||||
| EV-to-FCF | -1.14 | |||||
| Price-to-Median-PS-Value | 0.28 | |||||
| Price-to-Net-Current-Asset-Value | 1.7 | |||||
| Earnings Yield (Greenblatt) % | -91.46 | |||||
| FCF Yield % | -54.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syntara Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 4.484 | ||
| EPS (TTM) (A$) | -0.017 | ||
| Beta | 0.77 | ||
| Volatility % | 64.38 | ||
| 14-Day RSI | 42.53 | ||
| 14-Day ATR (A$) | 0.001596 | ||
| 20-Day SMA (A$) | 0.0185 | ||
| 12-1 Month Momentum % | -61.82 | ||
| 52-Week Range (A$) | 0.014 - 0.063 | ||
| Shares Outstanding (Mil) | 1,193.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syntara Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syntara Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syntara Ltd Frequently Asked Questions
What is Syntara Ltd(ASX:SNT)'s stock price today?
The current price of ASX:SNT is A$0.02. The 52 week high of ASX:SNT is A$0.06 and 52 week low is A$0.01.
When is next earnings date of Syntara Ltd(ASX:SNT)?
The next earnings date of Syntara Ltd(ASX:SNT) is .
Does Syntara Ltd(ASX:SNT) pay dividends? If so, how much?
Syntara Ltd(ASX:SNT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers